» Articles » PMID: 24460857

Alterations in Immune Cell Subsets and Their Cytokine Secretion Profile in Childhood Idiopathic Thrombocytopenic Purpura (ITP)

Overview
Date 2014 Jan 28
PMID 24460857
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Immune thrombocytopenic purpura (ITP) is acquired autoimmune disease in children characterized by the breakdown of immune tolerance. This work is designed to explore the contribution of different lymphocyte subsets in acute and chronic ITP children. Imbalance in the T helper type 1 (Th1)/Th2 cytokine secretion profile was investigated. The frequency of T (CD3(+), CD4(+), CD8(+)) and B (CD19(+)) lymphocytes, natural killer (NK) (CD16(+) 56(+)) and regulatory T (T(reg)) [CD4(+) CD25(+high) forkhead box protein 3 (FoxP3)(+) ] cells was investigated by flow cytometry in 35 ITP children (15 acute and 20 chronic) and 10 healthy controls. Plasma levels of Th1 cytokines [interferon (IFN-γ) and tumour necrosis factor (TNF-α)] and Th2 [interleukin (IL)-4, IL-6 and IL-10)] cytokines were measured using enzyme-linked immunosorbent assay (ELISA). The percentage of Treg (P < 0·001) and natural killer (NK) (P < 0·001) cells were significantly decreased in ITP patients compared to healthy controls. A negative correlation was reported between the percentage of T(reg) cells and development of acute (r = -0·737; P < 0·01) and chronic (r = -0·515; P < 0·01) disease. All evaluated cytokines (IFN-γ, TNF-α, IL-4, IL-6 and IL-10) were elevated significantly in ITP patients (P < 0·001, P < 0·05, P < 0·05, P < 0·05 and P < 0·001, respectively) compared to controls. In conclusion, our data shed some light on the fundamental role of immune cells and their related cytokines in ITP patients. The loss of tolerance in ITP may contribute to the dysfunction of T(regs). Understanding the role of T cell subsets will permit a better control of autoimmunity through manipulation of their cytokine network.

Citing Articles

Advancements and Future Directions of Dual-Target Chimeric Antigen Receptor T-Cell Therapy in Preclinical and Clinical Studies.

Zhang C, Liu H J Immunol Res. 2025; 2025():5845167.

PMID: 39844819 PMC: 11753851. DOI: 10.1155/jimr/5845167.


CpG can induce the proliferation and differentiation of B10 cells in the peripheral blood of children with immune thrombocytopenic purpura.

Gu S, Chen M, Xu W, Zhang H, Zhou H Ann Hematol. 2024; .

PMID: 39614925 DOI: 10.1007/s00277-024-06105-z.


The decreased of peripheral blood natural killer cell is associated with serum IL-2 level in the renal tubular acidosis in patients with primary sjogren's syndrome.

Cheng L, Liu L, Su R, Yan H, Zi X, Gao C BMC Immunol. 2023; 24(1):17.

PMID: 37391717 PMC: 10314557. DOI: 10.1186/s12865-023-00550-7.


Identification of ORM1, vWF, SPARC, and PPBP as immune-related proteins involved in immune thrombocytopenia by quantitative LC-MS/MS.

Yin D, Yuan D, Sun R, Xu H, Hun S, Sui X Clin Proteomics. 2023; 20(1):24.

PMID: 37355563 PMC: 10290381. DOI: 10.1186/s12014-023-09413-0.


Role of Long non Coding RNAs, NEAT1 and Lnc-DC Expression in Pediatric Immune Thrombocytopenic Purpura.

Hamdy S, Ali M, El-Hmid R, Abdelghaffar N, Abdelaleem O Rep Biochem Mol Biol. 2023; 11(4):635-643.

PMID: 37131890 PMC: 10149135. DOI: 10.52547/rbmb.11.4.635.


References
1.
Fahim N, Monir E . Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura. Egypt J Immunol. 2007; 13(1):173-87. View

2.
Jonuleit H, Schmitt E . The regulatory T cell family: distinct subsets and their interrelations. J Immunol. 2003; 171(12):6323-7. DOI: 10.4049/jimmunol.171.12.6323. View

3.
BONNYNS M, Bentin J, Devetter G, Duchateau J . Heterogeneity of immunoregulatory T cells in human thyroid autoimmunity: influence of thyroid status. Clin Exp Immunol. 1983; 52(3):629-34. PMC: 1536052. View

4.
Yabuhara A, Yang F, Nakazawa T, Iwasaki Y, Mori T, Koike K . A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J Rheumatol. 1996; 23(1):171-7. View

5.
Takahashi K, Miyake S, Kondo T, Terao K, Hatakenaka M, Hashimoto S . Natural killer type 2 bias in remission of multiple sclerosis. J Clin Invest. 2001; 107(5):R23-9. PMC: 199428. DOI: 10.1172/JCI11819. View